Lawrence Sterling Honig
#162,842
Most Influential Person Now
Lawrence Sterling Honig's AcademicInfluence.com Rankings
Lawrence Sterling Honigmedical Degrees
Medical
#3305
World Rank
#3772
Historical Rank
Neurology
#303
World Rank
#385
Historical Rank
Download Badge
Medical
Why Is Lawrence Sterling Honig Influential?
(Suggest an Edit or Addition)Lawrence Sterling Honig's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study (2013) (2210)
- Common variants in MS4A4/MS4A6E, CD2uAP, CD33, and EPHA1 are associated with late-onset Alzheimer’s disease (2011) (1656)
- Diagnosis and management of dementia with Lewy bodies (2017) (1606)
- Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease. (2014) (1543)
- Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing (2019) (1073)
- Aggregation of vascular risk factors and risk of incident Alzheimer disease (2005) (780)
- Early role of vascular dysregulation on late-onset Alzheimer's disease based on multifactorial data-driven analysis (2016) (716)
- Hippocampal and entorhinal atrophy in mild cognitive impairment (2007) (706)
- Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease (2017) (693)
- Trial of Solanezumab for Mild Dementia Due to Alzheimer's Disease (2018) (628)
- Interplay of LRRK2 with chaperone-mediated autophagy (2013) (515)
- Neuropathological changes in essential tremor: 33 cases compared with 21 controls. (2007) (500)
- Comparative Lipidomic Analysis of Mouse and Human Brain with Alzheimer Disease* (2011) (440)
- RAB7L1 Interacts with LRRK2 to Modify Intraneuronal Protein Sorting and Parkinson’s Disease Risk (2013) (437)
- Amyloid-related imaging abnormalities in patients with Alzheimer's disease treated with bapineuzumab: a retrospective analysis (2012) (390)
- Model‐guided microarray implicates the retromer complex in Alzheimer's disease (2005) (368)
- A multicenter study of glucocerebrosidase mutations in dementia with Lewy bodies. (2013) (357)
- Plasma A&bgr;40 and A&bgr;42 and Alzheimer’s disease: Relation to age, mortality, and risk (2003) (342)
- Stroke and the risk of Alzheimer disease. (2003) (339)
- A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease (2009) (327)
- Common genetic variants in the CLDN2 and PRSS1-PRSS2 loci alter risk for alcohol-related and sporadic pancreatitis (2012) (308)
- Delusions and hallucinations are associated with worse outcome in Alzheimer disease. (2005) (296)
- Common variants at MS 4 A 4 / MS 4 A 6 E , CD 2 AP , CD 33 and EPHA 1 are associated with late-onset Alzheimer ’ s disease (2011) (274)
- Apoptosis and neurologic disease. (2000) (267)
- Seizures in Alzheimer disease: who, when, and how common? (2009) (250)
- Retromer deficiency observed in Alzheimer's disease causes hippocampal dysfunction, neurodegeneration, and Aβ accumulation (2008) (243)
- Research criteria for the diagnosis of prodromal dementia with Lewy bodies (2020) (232)
- Motor signs during the course of Alzheimer disease (2004) (216)
- Variably protease‐sensitive prionopathy: A new sporadic disease of the prion protein (2010) (207)
- Basal forebrain degeneration precedes and predicts the cortical spread of Alzheimer's pathology (2016) (201)
- Four distinct trajectories of tau deposition identified in Alzheimer’s disease (2021) (200)
- Plasma A[beta]40 and A[beta]42 and Alzheimer's disease: relation to age, mortality, and risk. (2003) (198)
- Reduced Purkinje cell number in essential tremor: a postmortem study. (2008) (197)
- Extracellular Tau Oligomers Produce An Immediate Impairment of LTP and Memory (2016) (195)
- Exceptionally low likelihood of Alzheimer’s dementia in APOE2 homozygotes from a 5,000-person neuropathological study (2019) (194)
- Motor signs predict poor outcomes in Alzheimer disease (2005) (189)
- Genetic analysis implicates APOE, SNCA and suggests lysosomal dysfunction in the etiology of dementia with Lewy bodies (2014) (185)
- Aging and Alzheimer's disease: lessons from the Nun Study. (1998) (179)
- Seizures and Epilepsy in Alzheimer's Disease (2012) (175)
- Association of glucocerebrosidase mutations with dementia with lewy bodies. (2009) (175)
- Shorter telomeres are associated with mortality in those with APOE ϵ4 and dementia (2006) (166)
- Investigating the genetic architecture of dementia with Lewy bodies: a two-stage genome-wide association study (2018) (163)
- Ferritin levels in the cerebrospinal fluid predict Alzheimer's disease outcomes and are regulated by APOE (2015) (161)
- Association of shorter leukocyte telomere repeat length with dementia and mortality. (2012) (151)
- Measuring cerebral atrophy and white matter hyperintensity burden to predict the rate of cognitive decline in Alzheimer disease. (2008) (144)
- Disruptive behavior as a predictor in Alzheimer disease. (2007) (144)
- Neuropathologic findings in essential tremor (2006) (143)
- Neurogenic radial glial cells in reptile, rodent and human: from mitosis to migration. (2003) (143)
- Agrin isoforms and their role in synaptogenesis. (1992) (140)
- Effects of multiple genetic loci on age at onset in late-onset Alzheimer disease: a genome-wide association study. (2014) (140)
- Developmental changes revealed by immunohistochemical markers in human cerebral cortex. (1996) (137)
- Predicting Alzheimer’s disease progression using multi-modal deep learning approach (2019) (136)
- Atherosclerosis and AD (2005) (131)
- Natural history of Alzheimer’s disease (2001) (128)
- Essential tremor associated with focal nonnigral Lewy bodies: a clinicopathologic study. (2005) (127)
- Altered amyloid protein processing in platelets of patients with Alzheimer disease. (1997) (122)
- "Hairy Baskets" Associated With Degenerative Purkinje Cell Changes in Essential Tremor (2010) (119)
- Neural differentiation, NCAM-mediated adhesion, and gap junctional communication in neuroectoderm. A study in vitro (1988) (118)
- A trial of gantenerumab or solanezumab in dominantly inherited Alzheimer’s disease (2021) (113)
- Essential tremor associated with pathologic changes in the cerebellum. (2006) (111)
- Covariance PET patterns in early Alzheimer's disease and subjects with cognitive impairment but no dementia: utility in group discrimination and correlations with functional performance (2004) (106)
- Quantitative electron microscopy of microtubule assembly in vitro. (1975) (106)
- Hexanucleotide repeat expansions in C9ORF72 in the spectrum of motor neuron diseases (2012) (104)
- Alzheimer's disease and its Lewy body variant: a clinical analysis of postmortem verified cases. (1996) (101)
- Glutamate transporter EAAT2 splice variants occur not only in ALS, but also in AD and controls (2000) (100)
- Genome sequencing analysis identifies new loci associated with Lewy body dementia and provides insights into its genetic architecture (2021) (99)
- Functional brain architecture is associated with the rate of tau accumulation in Alzheimer’s disease (2020) (96)
- Shorter telomeres are associated with mortality in those with APOE epsilon4 and dementia. (2006) (95)
- Plasma p‐tau181, p‐tau217, and other blood‐based Alzheimer's disease biomarkers in a multi‐ethnic, community study (2020) (90)
- Safety of the tau-directed monoclonal antibody BIIB092 in progressive supranuclear palsy: a randomised, placebo-controlled, multiple ascending dose phase 1b trial (2019) (85)
- Magnetic resonance imaging of spinal cord lesions in multiple sclerosis. (1989) (84)
- Potential genetic modifiers of disease risk and age at onset in patients with frontotemporal lobar degeneration and GRN mutations: a genome-wide association study (2018) (83)
- Maps of strength of positional signalling activity in the developing chick wing bud. (1985) (82)
- ASSOCIATION BETWEEN GENETIC VARIANTS IN SORL1 AND AUTOPSY-CONFIRMED ALZHEIMER DISEASE (2008) (77)
- Torpedoes in Parkinson's disease, Alzheimer's disease, essential tremor, and control brains (2009) (76)
- Atherosclerosis and AD: analysis of data from the US National Alzheimer's Coordinating Center. (2005) (75)
- Genome-wide analysis of genetic correlation in dementia with Lewy bodies, Parkinson's and Alzheimer's diseases (2016) (74)
- Non-coding variability at the APOE locus contributes to the Alzheimer’s risk (2019) (74)
- Effects of Practice on Category Fluency in Alzheimers Disease* (2001) (71)
- Event-related potential P300 in multiple sclerosis. Relation to magnetic resonance imaging and cognitive impairment. (1992) (70)
- Antibodies to murine amelogenins: localization of enamel proteins during tooth organ development in vitro. (1982) (70)
- Robust Identification of Alzheimer’s Disease subtypes based on cortical atrophy patterns (2017) (69)
- Treatment and prognostic factors for long-term outcome in patients with anti-N-Methyl-D-Aspartate (NMDA) receptor encephalitis: a cohort study (2013) (66)
- Comparison of Pittsburgh compound B and florbetapir in cross-sectional and longitudinal studies (2019) (66)
- Mediterranean diet and leukocyte telomere length in a multi-ethnic elderly population (2014) (66)
- Identification of tubulin from the yeast Saccharomyces cerevisiae. (1978) (64)
- Exploring the structure of a neuropsychological battery across healthy elders and those with questionable dementia and Alzheimer's disease. (2008) (63)
- Genome-wide analyses as part of the international FTLD-TDP whole-genome sequencing consortium reveals novel disease risk factors and increases support for immune dysfunction in FTLD (2019) (63)
- Early neuropsychological discriminants for Lewy body disease: an autopsy series (2013) (62)
- Role of Amyloid-β and Tau Proteins in Alzheimer's Disease: Confuting the Amyloid Cascade. (2018) (61)
- Soluble amyloid beta levels are elevated in the white matter of Alzheimer’s patients, independent of cortical plaque severity (2014) (61)
- Depressive symptoms, vascular risk factors, and Alzheimer's disease (2008) (60)
- Heritability of telomere length in a study of long-lived families (2015) (60)
- Positional signal transmission in the developing chick limb (1981) (60)
- Older onset essential tremor: More rapid progression and more degenerative pathology (2009) (59)
- Association of common genetic variants in GPCPD1 with scaling of visual cortical surface area in humans (2012) (59)
- Longitudinal measurement and hierarchical classification framework for the prediction of Alzheimer’s disease (2017) (58)
- The developing avian retina expresses agrin isoforms during synaptogenesis. (1996) (58)
- Δ5-3β-hydroxysteroid dehydrogenase activity in sebaceous glands of scalp in male-pattern baldness (1988) (58)
- Intention tremor of the head in patients with essential tremor (2006) (57)
- Cognitive reserve-mediated modulation of positron emission tomographic activations during memory tasks in Alzheimer disease. (2004) (57)
- Increased androgen binding capacity in sebaceous glands in scalp of male-pattern baldness. (1989) (57)
- Challenges and Opportunities with Causal Discovery Algorithms: Application to Alzheimer’s Pathophysiology (2020) (56)
- Genetic factors for the development of Alzheimer disease in the Cherokee Indian. (1996) (56)
- Apolipoprotein eϵ4, other risk factors, and course of alzheimer’s disease (1999) (53)
- Most cases of dementia with hippocampal sclerosis may represent frontotemporal dementia (2005) (52)
- The BIN1 rs744373 SNP is associated with increased tau-PET levels and impaired memory (2019) (52)
- Depressive Symptoms Are Not Associated with Leukocyte Telomere Length: Findings from the Nova Scotia Health Survey (NSHS95), a Population-Based Study (2012) (51)
- Three-Word Recall in Normal Aging (2004) (51)
- Brain arterial aging and its relationship to Alzheimer dementia (2016) (48)
- PARK10 is a major locus for sporadic neuropathologically confirmed Parkinson disease (2015) (48)
- Genome wide association and linkage analyses identified three loci—4q25, 17q23.2, and 10q11.21—associated with variation in leukocyte telomere length: the Long Life Family Study (2014) (45)
- The Control of Pattern Across the Antero-Posterior Axis of the Chick Limb Bud by a Unique Signalling Region (1982) (45)
- Effect of CLU genetic variants on cerebrospinal fluid and neuroimaging markers in healthy, mild cognitive impairment and Alzheimer’s disease cohorts (2016) (44)
- Frequency of GBA Variants in Autopsy‐proven Multiple System Atrophy (2017) (43)
- Clinical and Pathological Characteristics of LRRK2 G2019S Patients with PD (2012) (42)
- Rarity of the Alzheimer disease-protective APP A673T variant in the United States. (2015) (39)
- A Pathological Perspective on the Natural History of Cerebral Atherosclerosis (2015) (39)
- Immunotherapy with ponezumab for probable cerebral amyloid angiopathy (2019) (39)
- Expression, distribution and ultrastructural localization of the synapse‐organizing molecule agrin in the mature avian retina (1999) (38)
- Memory performance is related to amyloid and tau pathology in the hippocampus (2009) (37)
- Mining Outcome-relevant Brain Imaging Genetic Associations via Three-way Sparse Canonical Correlation Analysis in Alzheimer’s Disease (2017) (36)
- Age and Sex Distributions of Age‐Related Biomarker Values in Healthy Older Adults from the Long Life Family Study (2016) (36)
- Relationship between caffeine intake and Parkinson disease. (2000) (35)
- Apolipoprotein E epsilon 4, other risk factors, and course of Alzheimer's disease. (1999) (35)
- Predicting Short-term MCI-to-AD Progression Using Imaging, CSF, Genetic Factors, Cognitive Resilience, and Demographics (2019) (35)
- Parkinsonism during cyclosporine treatment. (1996) (32)
- A quantitative perspective to the study of brain arterial remodeling of donors with and without HIV in the Brain Arterial Remodeling Study (BARS) (2014) (32)
- Relation between leukocyte telomere length and incident coronary heart disease events (from the 1995 Canadian Nova Scotia Health Survey). (2013) (30)
- Anti-N-methyl-D-aspartate receptor encephalitis: an emerging cause of centrally mediated sinus node dysfunction. (2012) (29)
- Genetic studies of plasma analytes identify novel potential biomarkers for several complex traits (2016) (28)
- Author Correction: Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing (2019) (26)
- Women can bear a bigger burden: ante- and post-mortem evidence for reserve in the face of tau (2020) (26)
- Alzheimer's-related changes in non-demented essential tremor patients vs. controls: links between tau and tremor? (2014) (26)
- Effects of biochemical inhibitors on positional signalling in the chick limb bud. (1981) (25)
- Analysis of neurodegenerative disease-causing genes in dementia with Lewy bodies (2020) (25)
- A Case of Progressive Apraxia of Speech in Pathologically Verified Alzheimer Disease (2007) (25)
- Absence of C9ORF72 expanded or intermediate repeats in autopsy‐confirmed Parkinson's disease (2014) (25)
- Tau and other proteins found in Alzheimer’s disease spinal fluid are linked to retromer-mediated endosomal traffic in mice and humans (2020) (25)
- Heritability and genetic variance of dementia with Lewy bodies (2018) (25)
- Early Selective Vulnerability of the CA2 Hippocampal Subfield in Primary Age-Related Tauopathy. (2020) (25)
- Accelerated functional brain aging in pre-clinical familial Alzheimer’s disease (2021) (25)
- Does anterior (non-polarizing region) tissue signal in the developing chick limb? (1983) (24)
- A neural network design for event-related potential diagnosis. (1993) (24)
- Determinants of cerebrovascular remodeling: do large brain arteries accommodate stenosis? (2014) (23)
- Telomere length is longer in women with late maternal age (2017) (23)
- Role of Amyloid-β and Tau Proteins in Alzheimer's Disease: Confuting the Amyloid Cascade. (2019) (22)
- Neural network analysis of the P300 event-related potential in multiple sclerosis. (1994) (22)
- 18F-florbetapir Positron Emission Tomography–determined Cerebral &bgr;-Amyloid Deposition and Neurocognitive Performance after Cardiac Surgery (2018) (21)
- Multiple sclerosis: correlation of magnetic resonance imaging with cerebrospinal fluid findings. (1988) (20)
- Cascaded Multi-view Canonical Correlation (CaMCCo) for Early Diagnosis of Alzheimer’s Disease via Fusion of Clinical, Imaging and Omic Features (2017) (20)
- A Novel Joint Brain Network Analysis Using Longitudinal Alzheimer’s Disease Data (2019) (19)
- KL-VS heterozygosity is associated with lower amyloid-dependent tau accumulation and memory impairment in Alzheimer’s disease (2021) (19)
- Safety, Tolerability, and Pharmacokinetics of Crenezumab in Patients with Mild-to-Moderate Alzheimer’s Disease Treated with Escalating Doses for up to 133 Weeks (2020) (19)
- Clinical Experience with Cerebrospinal Fluid Aβ42, Total and Phosphorylated Tau in the Evaluation of 1,016 Individuals for Suspected Dementia (2018) (17)
- Ischemic brain damage. (1991) (17)
- Epithelial-derived basal lamina regulation of mesenchymal cell differentiation. (1982) (17)
- Genome-wide association analysis of hippocampal volume identifies enrichment of neurogenesis-related pathways (2016) (16)
- The Longitudinal Early‐onset Alzheimer's Disease Study (LEADS): Framework and methodology (2021) (16)
- Predicting Cognitive Improvement in Normal Pressure Hydrocephalus Patients Using Preoperative Neuropsychological Testing and Cerebrospinal Fluid Biomarkers. (2019) (16)
- A comprehensive screening of copy number variability in dementia with Lewy bodies (2019) (16)
- Plasma phosphorylated-tau181 as a predictive biomarker for Alzheimer’s amyloid, tau and FDG PET status (2021) (16)
- A Randomized, Double-Blind, Phase 2 Study of the Effects of the Vaccine Vanutide Cridificar with QS-21 Adjuvant on Immunogenicity, Safety and Amyloid Imaging in Patients with Mild to Moderate Alzheimer's Disease. (2016) (15)
- Regional Amyloid-β Load and White Matter Abnormalities Contribute to Hypometabolism in Alzheimer’s Dementia (2018) (15)
- Reduced Purkinje Cell Number in Essential Tremor (2008) (15)
- Tonic spasms in multiple sclerosis. Anatomic basis and treatment. (1991) (15)
- Allele-specific DNA methylation is increased in cancers and its dense mapping in normal plus neoplastic cells increases the yield of disease-associated regulatory SNPs (2019) (14)
- Enamel gene products during murine amelogenesis in vivo and in vitro. (1982) (14)
- Short telomere length is associated with renal impairment in Japanese subjects with cardiovascular risk (2017) (14)
- Olfactory impairment is related to tau pathology and neuroinflammation in Alzheimer's disease (2020) (14)
- Analysis of C9orf72 repeat expansions in a large international cohort of dementia with Lewy bodies (2017) (13)
- Long-Term Follow Up of Patients with Mild-to-Moderate Alzheimer's Disease Treated with Bapineuzumab in a Phase III, Open-Label, Extension Study. (2018) (13)
- Polarizing activity of the avian limb examined on a cellular basis. (1983) (13)
- Wolframin is a novel regulator of tau pathology and neurodegeneration (2022) (12)
- LRP10 in α-synucleinopathies (2018) (12)
- A semi-mechanism approach based on MRI and proteomics for prediction of conversion from mild cognitive impairment to Alzheimer’s disease (2016) (12)
- Laboratory biomarkers in Alzheimer’s disease (2007) (12)
- Staging tau pathology with tau PET in Alzheimer’s disease: a longitudinal study (2021) (12)
- Microtubule protein preparations from C6 glial cells and their spontaneous polymer formation (1979) (11)
- Neurologists and the Internet. (1999) (11)
- Treatment of Alzheimer’s Disease: Current Management and Experimental Therapeutics (2013) (11)
- Translational research in neurology: dementia. (2012) (11)
- Hippocampal laminar distribution of tau relates to Alzheimer's disease and age of onset. (2014) (10)
- Inflammation in neurodegenerative disease: good, bad, or irrelevant? (2000) (10)
- The impact of PICALM genetic variations on reserve capacity of posterior cingulate in AD continuum (2016) (10)
- Introduction to Neuropsychology, 2nd ed (2009) (10)
- Characterization of initiated cells in N-methylnitrosourea-induced carcinogenesis of the CNS in the adult rat. (2001) (10)
- Evaluating the Safety and Efficacy of Crenezumab vs Placebo in Adults With Early Alzheimer Disease (2022) (9)
- delta 5-3 beta-hydroxysteroid dehydrogenase activity in sebaceous glands of scalp in male-pattern baldness. (1988) (9)
- FAM222A encodes a protein which accumulates in plaques in Alzheimer’s disease (2020) (9)
- Higher CSF sTNFR1-related proteins associate with better prognosis in very early Alzheimer’s disease (2021) (9)
- Amyloid-associated increases in soluble tau relate to tau aggregation rates and cognitive decline in early Alzheimer’s disease (2022) (9)
- Lewy Body Dementia Association’s Research Centers of Excellence Program: Inaugural Meeting Proceedings (2019) (8)
- Dementia with cerebrovascular disease. (2006) (8)
- A telescope GWAS analysis strategy, based on SNPs-genes-pathways ensamble and on multivariate algorithms, to characterize late onset Alzheimer’s disease (2020) (8)
- Influence of the Major Histocompatibility Complex (H-2) on Glucocorticoid-Stimulated Pulmonary Surfactant Synthesis in Two Congenic Mouse Strains 1 (1984) (8)
- Biochemical Inhibition of Positional Signalling in the Avian Limb Bud (1982) (7)
- Gene Therapy in Alzheimer Disease-It May Be Feasible, but Will It Be Beneficial? (2018) (7)
- Correlation between Alzheimer’s disease and type 2 diabetes using non-negative matrix factorization (2021) (7)
- HTLV‐I‐associated myelopathy in a Californian (1991) (7)
- Genome sequencing analysis identifies new loci associated with Lewy body dementia and provides insights into the complex genetic architecture (2020) (7)
- Fluid and Tissue Biomarkers of Lewy Body Dementia: Report of an LBDA Symposium (2021) (7)
- A predictive model using the mesoscopic architecture of the living brain to detect Alzheimer’s disease (2022) (7)
- Pathological correlates of brain arterial calcifications. (2019) (7)
- Low tobacco-related cancer incidence in offspring of long-lived siblings: a comparison with Danish national cancer registry data. (2015) (7)
- Predicting Alzheimer’s disease progression using multi-modal deep learning approach (2019) (6)
- Uncovering the heterogeneity and temporal complexity of neurodegenerative diseases with Subtype and Stage Inference (2018) (6)
- Comprehensive analysis of epigenetic clocks reveals associations between disproportionate biological ageing and hippocampal volume (2022) (6)
- Dissociation of tau pathology and neuronal hypometabolism within the ATN framework of Alzheimer’s disease (2022) (6)
- Experimental dissection of avian and murine tissue interactions using organ culture in a serumless medium free from exogenous (nondefined) factors. (1982) (6)
- Presenting Neuropsychological Testing Profile of Autopsy-Confirmed Frontotemporal Lobar Degeneration (2013) (5)
- The BIN1 rs744373 SNP is associated with increased tau-PET levels and impaired memory (2019) (5)
- An IL1RL1 genetic variant lowers soluble ST2 levels and the risk effects of APOE-ε4 in female patients with Alzheimer’s disease (2022) (5)
- In vivo and in vitro development of first branchial arch derivatives in Alligator mississippiensis. (1982) (5)
- Smoking and Parkinson's disease. (1999) (5)
- Patterns of tau pathology identified with 18F‐MK‐6240 PET imaging (2021) (5)
- Tic or dystonia? (1992) (5)
- Multiple Ascending Dose Study of the Tau-Directed Monoclonal Antibody BIIB092 in Patients with Progressive Supranuclear Palsy (S27.004) (2018) (5)
- Importance of Symptomatic Cerebral Infarcts on Cognitive Performance in Patients with Alzheimer's Disease (2011) (4)
- RAB7L1 Interacts with LRRK2 to Modify Intraneuronal Protein Sorting and Parkinson’s Disease Risk (2013) (4)
- Effect of CLU genetic variants on cerebrospinal fluid and neuroimaging markers in healthy, mild cognitive impairment and Alzheimer’s disease cohorts (2016) (4)
- Leukocyte Telomere Length Is Unrelated to Cognitive Performance Among Non-Demented and Demented Persons: An Examination of Long Life Family Study Participants (2020) (4)
- Gantenerumab in‐depth outcomes: Results of the DIAN‐TU prevention trial of solanezumab and gantenerumab in dominantly inherited AD (2020) (4)
- Dissection of the polygenic architecture of neuronal Aβ production using a large sample of individual iPSC lines derived from Alzheimer’s disease patients (2022) (4)
- Overview of dominantly inherited AD and top‐line DIAN‐TU results of solanezumab and gantenerumab (2020) (4)
- Manifestations of Alzheimer’s disease genetic risk in the blood are evident in a multiomic analysis in healthy adults aged 18 to 90 (2022) (4)
- Feature extraction of event-related potential waveforms by neural networks (1993) (3)
- Glucose metabolism patterns: A potential index to characterize brain ageing and predict high conversion risk into cognitive impairment (2022) (3)
- Functional brain architecture is associated with the rate of tau accumulation in Alzheimer’s disease (2020) (3)
- Cerebrospinal fluid amyloid levels are associated with delayed memory retention in cognitively normal biomarker-negative older adults (2019) (3)
- Challenges and Opportunities with Causal Discovery Algorithms: Application to Alzheimer’s Pathophysiology (2020) (3)
- Brain tumor-associated dementia. (2005) (3)
- Neural networks for EEG diagnosis (1992) (3)
- Subacute Imbalance in a Renal Transplant Patient. (2015) (3)
- Correlation of plasma and neuroimaging biomarkers in Alzheimer's disease (2022) (3)
- Anterolateral entorhinal cortex volume is associated with memory retention in clinically unimpaired older adults (2020) (3)
- Experimental fusion of the naturally cleft, embryonic chick palate. (1985) (2)
- Who, When, and How Common? (2009) (2)
- Effects of ultraviolet light on the activity of an avian limb positional signalling region. (1982) (2)
- Absence of C 9 ORF 72 expanded or intermediate repeats in autopsy confirmed Parkinson Disease (2014) (2)
- Sex‐associated differences in pathology burden in early‐onset Alzheimer’s disease (2020) (2)
- Frontotemporal degenerative dementias (2004) (2)
- Frontotemporal dementia. (2003) (2)
- Alzheimer's disease. (2001) (2)
- Gantenerumab in‐depth outcomes (2020) (2)
- Blood-Based Biomarkers for Alzheimer’s Disease in Older Adults with Posttraumatic Stress Disorder (2022) (1)
- Author Correction: Spread of pathological tau proteins through communicating neurons in human Alzheimer’s disease (2021) (1)
- Parkinson's disease. (2001) (1)
- Solanezumab in‐depth outcomes (2020) (1)
- Antero-Posterior Positional Signalling in the Developing Chick Limb (1980) (1)
- PERIPHERAL NEUROPATHY IN VIRUS ASSOCIATED HEMOPHAGOCYTOSIS (VAH): 211 (1989) (1)
- Cerebrospinal fluid biomarkers in dementia with Lewy bodies (2013) (1)
- Amyloid and tau PET in sporadic early‐onset Alzheimer’s disease: Preliminary results from LEADS (2020) (1)
- Survival in amyotrophic lateral sclerosis. (1995) (1)
- O3-01-03: Retromer deficiency observed in Alzheimer's disease causes hippocampal dysfunction, neurodegeneration, and Abeta accumulation (2008) (1)
- Alligator mandibular development during long term organ culture (1983) (1)
- P3-090 MRI signal hyperintensities predict more rapid cognitive decline in Alzheimer's disease (AD) (2004) (1)
- Lewy bodies [13] (multiple letters) (1997) (1)
- Plasma and CSF biomarkers for Alzheimer’s disease among Caribbean Hispanics (2021) (1)
- P3-283 Biological aging: does telomere length predict dementia and mortality? (2004) (1)
- Personality change and gait dysfunction. (2015) (1)
- IN ABSENCE OF DEMENTIA, COGNITIVE PERFORMANCE DOES NOT RELATE TO THE BIOMARKER OF LEUKOCYTE TELOMERE LENGTH: AN EXAMINATION OF LONG LIFE FAMILY STUDY PARTICIPANTS (2018) (1)
- Avoid or Embrace? Practice Effects in Alzheimer’s Disease Prevention Trials (2022) (1)
- Abstract T P419: Pathological Arterial Wall Correlates of Lumen-based Remodeling: Results From the Brain Arterial Remodeling Study (2015) (1)
- ARIA in patients treated with lecanemab (BAN2401) in a phase 2 study in early Alzheimer's disease (2023) (0)
- IC-P-123 Greater cerebral atrophy predicts more rapid cognitive decline in Alzheimer’s disease (2006) (0)
- DOES ACQUISITION TIME AFFECT THE RESULTS OF 18F-FLORBETABEN IMAGING? (2019) (0)
- Effects of short-term repeated administrations of animal naming in demented and nondemented subjects (1999) (0)
- Soluble amyloid beta levels are elevated in the white matter of Alzheimer’s patients, independent of cortical plaque severity (2014) (0)
- Deep learning-based polygenic risk analysis for Alzheimer’s disease prediction (2023) (0)
- AGE-ANCHORING SCD TO OPTIMIZE ITS ASSOCIATION WITH CSF AD BIOMARKERS (2019) (0)
- Abstract 14571: Short Telomere Length is a Marker of Renal Aging in a Japanese Cohort (2016) (0)
- Exceptionally low likelihood of Alzheimer’s dementia in APOE2 homozygotes from a 5,000-person neuropathological study (2020) (0)
- Sex and APOE‐ε4 carrier effects on early‐onset Alzheimer’s disease pathology (2022) (0)
- SURVIVAL IN AMYOTROPHIC LATERAL SCLEROSIS. AUTHORS' REPLY (1995) (0)
- P3-372 Correlations of cognitive testing and spect perfusion imaging in corticobasal degeneration (CBD) (2004) (0)
- P2-223: Lewy body and Alzheimer pathological findings in the same brains: Coincidence or a common diathesis? (2008) (0)
- Association Studies of Neuropathologically-Confirmed Cases and Controls Reveals that the PARK10 Locus is a Major Contributor to Sporadic Parkinson disease. (S7.005) (2015) (0)
- Spread of pathological tau proteins through communicating neurons in human Alzheimer’s disease (2020) (0)
- Characteristic patterns of inter- and intra-hemispheric metabolic connectivity in patients with stable and progressive mild cognitive impairment and Alzheimer’s disease (2018) (0)
- Amyloid‐Related Imaging Abnormalities in the DIAN‐TU‐001 Trial of Gantenerumab and Solanezumab: Lessons from a Trial in Dominantly Inherited Alzheimer Disease (2022) (0)
- P4-315: Impaired attentional refractory period in Alzheimer's disease (2008) (0)
- Pattern Discovery in Brain Imaging Genetics via SCCA Modeling with a Generic Non-convex Penalty (2017) (0)
- Author Correction: Multimodal hippocampal subfield grading for Alzheimer’s disease classification (2020) (0)
- Long-term follow up of Alzheimer's patients treated with bapineuzumab in phase 2 (2011) (0)
- The impact of cerebrovascular disease on blood‐based biomarkers of Alzheimer’s disease (2021) (0)
- Evaluation of Plasma Biomarkers for A/T/N Classification of Alzheimer Disease Among Adults of Caribbean Hispanic Ethnicity (2023) (0)
- Risk Factors Associated with Cerebral Amyloid Angiopathy Lobar Hemorrhage: A Single Center Cohort Analysis (P6.056) (2016) (0)
- Author Correction: Multimodal hippocampal subfield grading for Alzheimer’s disease classification (2020) (0)
- P3-089 A covariance resting PET pattern that discriminates between healthy elderly and early AD patients correlates with functional and cognitive severity in subjects with cognitive impairment but no dementia (2004) (0)
- Longitudinal head-to-head comparison of 11C-PiB and 18F-florbetapir PET in a Phase 2/3 clinical trial of anti-amyloid-β monoclonal antibodies in dominantly inherited Alzheimer's disease. (2023) (0)
- JAMA Neurology Clinical Challenge Call for Papers (2015) (0)
- Genetics of Alzheimer's Disease (1997) (0)
- Regional Amyloid-β Load and White Matter Abnormalities Contribute to Hypometabolism in Alzheimer’s Dementia (2018) (0)
- SMOKING AND PARKINSON'S DISEASE. AUTHORS' REPLY (1999) (0)
- Plasma biomarkers Aβ42, Aβ40, and tau in Down syndrome dementia (2020) (0)
- Increased Number of Purkinje Cell Dendritic Swellings: Evidence of Another Structural Abnormality in Essential Tremor (P04.043) (2012) (0)
- Analysis of neurodegenerative disease-causing genes in dementia with Lewy bodies (2020) (0)
- Contents Vol. 36, 2013 (2013) (0)
- Prologue (2004) (0)
- Clinical and Pathological Characteristics of LRRK2 G2019S Patients with PD (2011) (0)
- Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing (2019) (0)
- Pooled biomarker analyses of phase 2 studies of vanutide cridificar vaccine (ACC-001) in mild-to-moderate and early Alzheimer’s disease (2015) (0)
- PLASMA AB40 AND AB42 DECLINE WITH PROGRESSION OF DEMENTIA (2014) (0)
- Aphasiology, Volume 28, List of Reviewers (2014) (0)
- Higher CSF sTREM2 attenuates ApoE4-related risk for cognitive decline and neurodegeneration (2020) (0)
- REVISE THE DSM CRITERIA FOR DEMENTIA (2005) (0)
- Translational Research in Neurology (2016) (0)
- DOES ACQUISITION TIME AFFECT THE RESULTS OF 18F-FLORBETABEN IMAGING? (2019) (0)
- Paroxysmal kinesigenic choreoathetosis. (1992) (0)
- The CERAD and the CVLT: A comparison of verbal learning measures in Alzheimer's disease (1997) (0)
- Education effects on verbal fluency performance in Alzheimer's disease (1997) (0)
- Gantnerumab In-depth Outcomes (2020) (0)
- Investigating the genetic architecture of Dementia with Lewy bodies: a genome-wide association study (2018) (0)
- GenEpi: gene-based epistasis discovery using machine learning (2020) (0)
- TIC OF DYSTONIA ? RESPOND (1992) (0)
- Depressive symptoms are not associated with leukocyte telomere length: findings from the Nova Scotia Health Survey (NSHS95) population-based study (2012) (0)
- Differential properties of Early vs. Late 18F‐Florbetaben imaging acquisition time frames (2022) (0)
- Differential properties of Early vs. Late 18F‐Florbetaben imaging acquisition time frames (2022) (0)
- P1-230: Frontal infarcts are associated with executive and language impairments in patients with Alzheimer's disease (2008) (0)
- The trend of disruption in the functional brain network topology of Alzheimer’s disease (2021) (0)
- Longitudinal Patterns of Cortical Atrophy on MRI in Patients With Alzheimer Disease With and Without Lewy Body Pathology (2022) (0)
- P1-267 The relation of depression to Alzheimer’s disease is not explained by vascular risk factors and stroke (2006) (0)
- ISCHEMIC BRAIN DAMAGE. REPLY (1991) (0)
- Telomere length in autopsy brain tissue in dementia (2010) (0)
- Hippocampal Laminar Distribution of Phospho-Tau Relates to Alzheimer’s Disease and Age of Death (P1.247) (2014) (0)
- RESPONSE TO AGING AND ALZHEIMER'S DISEASE : LESSONS FROM THE NUN STUDY. AUTHORS' REPLY (1998) (0)
- TELOMERE LENGTH IN HUMAN LEUKOCYTE SUBPOPULATIONS (2018) (0)
- Telomere Length Shortening in Alzheimer’s Disease (2011) (0)
- Predicting Short-term MCI-to-AD Progression Using Imaging, CSF, Genetic Factors, Cognitive Resilience, and Demographics (2019) (0)
- Increased white matter MRI T1 hypointensity volume in young‐onset Alzheimer’s disease patients is not accounted for by age or cardiovascular risk factors (2020) (0)
- Smoking and Parkinson's disease [1] (multiple letters) (1999) (0)
- Three word recall in normal aging: Effects of explicit prompts (1999) (0)
- Author Correction: FAM222A encodes a protein which accumulates in plaques in Alzheimer’s disease (2022) (0)
- Epilogue (2004) (0)
- O1-01-05: Memory performance is specifically related to amyloid and Tau pathology in the entorhinal cortex and hippocampus (2008) (0)
- Tangle-only dementia is associated with variation in the MAPT 3' UTR (2012) (0)
- O2-03-04 Retromer-mutant mice model features of late-onset Alzheimer’s disease (2006) (0)
- Growth and the origin of additional structures in reduplicated chick wings. (1983) (0)
- Cognitive, neuropsychiatric and imaging comparisons between early‐onset and late‐onset Alzheimer’s disease participants from LEADS and ADNI3 (2021) (0)
- Mediterranean diet and leukocyte telomere length in a multi-ethnic elderly population (2015) (0)
- Self- or Proxy-Reported Stroke and the Risk of Alzheimer Disease—Reply (2004) (0)
- Arteriosclerosis and Alzheimer's disease: A case-control pathologic study (2012) (0)
- THE LEWY BODY DEMENTIA ASSOCIATION RESEARCH CENTERS OF EXCELLENCE PROGRAM: TOWARD OPTIMIZING CLINICAL CARE AND CLINICAL TRIAL INFRASTRUCTURE (2018) (0)
- Neurodegeneration in the Longitudinal Evaluation of Early Onset Alzheimer’s Disease Study (LEADS) sample: Results from the MRI core (2020) (0)
- A blood-based signature of cerebrospinal fluid Aβ1–42 status (2019) (0)
- P2-266 Greater cerebral atrophy predicts more rapid cognitive decline in Alzheimer’s disease (2006) (0)
- Genome-wide association analysis of Dementia with Lewy bodies reveals unique genetic architecture (2017) (0)
- ADVANCING CLINICAL AND BIOMARKER RESEARCH IN AD: THE LEAD STUDY (2019) (0)
- Neuropathological autopsy findings in an individual with Alzheimer’s disease who received long‐term treatment with lecanemab (BAN2401) (2022) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Lawrence Sterling Honig?
Lawrence Sterling Honig is affiliated with the following schools:
